TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 10 | 8 | 14 | -4 | -26 | -69 | -11 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/19/22 07:14 | 12/16/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Willard Stephen H | DE | DO | CEO | P | 59 | 1.17 | 0 | 50 | New | 50 | D | ||||||||||||||
1/30/08 06:03 | 1/29/08 | ETFC | E Trade Financial Corp | DE | Financ | SvBnk | Savings Institution, Federall | Willard Stephen H | NY | D | P | 100 | 3.99 | 14 | 25 | 134 | 44 | D | -82 | -83 | -78 | -61 | 7 | 84 | 41 | 19 | 10 | 8 | 14 | -4 | -26 | -69 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |